Literature DB >> 33317138

Relation of α2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis.

Berthold Hoppe1,2, Christian Schwedler2, Hildrun Haibel3, Maryna Verba3, Fabian Proft3, Mikhail Protopopov3, Hans-Gert Heuft4, Valeria Rios Rodriguez3, Anke Edelmann5, Martin Rudwaleit3,6, Joachim Sieper3, Denis Poddubnyy3,7.   

Abstract

OBJECTIVE: Coagulation and fibrinolysis are interrelated with the expression of vascular endothelial growth factor (VEGF), which frequently is increased in axial spondyloarthritis (axSpA). We tested whether (i) α2-antiplasmin (A2AP) Arg6Trp, (ii) fibrinogen, factor XIII A-subunit or B-subunit genotypes are associated with VEGF levels and assessed whether the known association between elevated VEGF and radiographic spinal progression in axSpA depends on genetic background.
METHODS: One hundred and eighty-six axSpA patients from the German Spondyloarthritis Inception Cohort were genotyped, characterized for VEGF levels, and statistically analyzed. The association between VEGF and radiographic spinal progression was assessed in dependence on genetic background in stratified analyses.
RESULTS: A2AP 6Trp carriage was associated with VEGF elevation (OR: 2.37, 95% CI: 1.06-5.29) and VEGF levels (6Trp, 455 ± 334 pg/mL; 6Arg/Arg, 373 ± 293 pg/mL; p < 0.008). Association between elevated VEGF and radiographic spinal progression in axSpA (OR: 3.11, 95% CI: 1.02-8.82) depended remarkably on the fibrinogen (FGA) genotype. When considering axSpA patients with elevated VEGF, in FGA rs6050A>G wild types, 42.1% of patients (8 of 19) progressed, while in G-allele carriers, no radiographic progression happened (0 of 13) (p < 0.04).
CONCLUSIONS: The A2AP Arg6Trp genotype seems to influence VEGF levels in axSpA. The predictive value of VEGF elevations in respect of radiographic spinal progression in axSpA depends on FGA genotypes.

Entities:  

Keywords:  factor XIII; fibrinogen; fibrinolysis; spondyloarthritis; vascular endothelial growth factor; α2-antiplasmin

Mesh:

Substances:

Year:  2020        PMID: 33317138      PMCID: PMC7764219          DOI: 10.3390/ijms21249383

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  31 in total

1.  Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

Authors:  J P Collet; D Park; C Lesty; J Soria; C Soria; G Montalescot; J W Weisel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

Review 2.  Molecular and cellular modulation of fibrinolysis.

Authors:  Krasimir Kolev; Raymund Machovich
Journal:  Thromb Haemost       Date:  2003-04       Impact factor: 5.249

3.  Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk.

Authors:  Bernard C B Lim; Robert A S Ariëns; Angela M Carter; John W Weisel; Peter J Grant
Journal:  Lancet       Date:  2003-04-26       Impact factor: 79.321

4.  Factor XIII (FXIII) and angiogenesis.

Authors:  R Dardik; J Loscalzo; A Inbal
Journal:  J Thromb Haemost       Date:  2005-08-26       Impact factor: 5.824

5.  A common mutation (G-455--> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study.

Authors:  A Tybjaerg-Hansen; B Agerholm-Larsen; S E Humphries; S Abildgaard; P Schnohr; B G Nordestgaard
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

6.  Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis.

Authors:  Denis Poddubnyy; Kristina Conrad; Hildrun Haibel; Uta Syrbe; Heiner Appel; Jürgen Braun; Martin Rudwaleit; Joachim Sieper
Journal:  Ann Rheum Dis       Date:  2013-08-16       Impact factor: 19.103

7.  The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo.

Authors:  Florian M Kovar; Claudia Marsik; Bernd Jilma; Christine Mannhalter; Peter Quehenberger; Silvia Handler; Oswald F Wagner; Georg Endler
Journal:  Thromb Res       Date:  2007-02-15       Impact factor: 3.944

8.  ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis.

Authors:  Maxime Dougados; Paternotte Simon; Juergen Braun; Ruben Burgos-Vargas; Walter P Maksymowych; Joachim Sieper; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2010-09-09       Impact factor: 19.103

Review 9.  Vascular endothelial growth factor control mechanisms in skeletal growth and repair.

Authors:  Kai Hu; Bjorn R Olsen
Journal:  Dev Dyn       Date:  2016-12-29       Impact factor: 3.780

10.  Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system.

Authors:  M C W Creemers; M J A M Franssen; M A van't Hof; F W J Gribnau; L B A van de Putte; P L C M van Riel
Journal:  Ann Rheum Dis       Date:  2004-03-29       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.